Agenus (AGEN) Cash & Current Investments (2010 - 2026)
Agenus (AGEN) posted quarterly Cash & Current Investments of $35.0 million for Q1 2026, up 89.29% year-over-year from $18.5 million in Q1 2025, and up 1067.31% quarter-over-quarter from $3.0 million in Q4 2025.
Agenus (AGEN) Cash & Current Investments (2010 - 2026) Analysis & Trends
Agenus' Cash & Current Investments history runs 17 years deep, the most recent figure standing at $35.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 89.29% year-over-year to $35.0 million; the TTM figure through Mar 2026 stood at $35.0 million (up 89.29% YoY), while the FY2025 annual figure was $3.0 million, down 92.59% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $35.0 million, up from $3.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $262.7 million in Q1 2022, with the low at $3.0 million in Q4 2025.
- The 5-year median for Cash & Current Investments is $76.1 million (2023), against an average of $102.6 million.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments jumped 224.07% in 2022, then slumped 92.59% in 2025.
- Agenus' Cash & Current Investments stood at $193.4 million in 2022, then tumbled by 60.64% to $76.1 million in 2023, then sank by 46.87% to $40.4 million in 2024, then plunged by 92.59% to $3.0 million in 2025, then soared by 1067.31% to $35.0 million in 2026.
- Business Quant data shows AGEN's Cash & Current Investments at $35.0 million in Q1 2026, $3.0 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 836.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.16 Bn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | 18.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.74 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Jun 30, 2025 | 9.53 Mn |
| Mar 31, 2025 | 18.49 Mn |
| Dec 31, 2024 | 40.44 Mn |
| Sep 30, 2024 | 44.78 Mn |
| Jun 30, 2024 | 93.72 Mn |
| Mar 31, 2024 | 52.86 Mn |
| Dec 31, 2023 | 76.11 Mn |
| Sep 30, 2023 | 106.31 Mn |
| Jun 30, 2023 | 157.85 Mn |
| Mar 31, 2023 | 189.23 Mn |
| Dec 31, 2022 | 193.36 Mn |
| Sep 30, 2022 | 218.23 Mn |
| Jun 30, 2022 | 238.33 Mn |
| Mar 31, 2022 | 262.69 Mn |
| Dec 31, 2021 | 306.92 Mn |
| Sep 30, 2021 | 261.53 Mn |